Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Myelodysplastic Syndromes 97Leukemia 94Leukemia, Myeloid, Acute 85Precursor Cell Lymphoblastic Leukemia-Lymphoma 71Lymphoma 65Leukemia, Lymphocytic, Chronic, B-Cell 61Lymphoma, Non-Hodgkin 56Multiple Myeloma 55Hodgkin Disease 51Leukemia, Myeloid, Chronic-Phase 48Myeloproliferative Disorders 47Leukemia, Myeloid, Accelerated Phase 45Lymphoma, Follicular 43Lymphoma, Mantle-Cell 42Lymphoma, Large B-Cell, Diffuse 42Lymphoma, B-Cell, Marginal Zone 41Congenital Abnormalities 40Burkitt Lymphoma 40Neoplasms, Plasma Cell 38Lymphoma, Large-Cell, Immunoblastic 35Graft vs Host Disease 32Blast Crisis 32Leukemia, Myelomonocytic, Chronic 30Primary Myelofibrosis 29Anemia, Refractory, with Excess of Blasts 29Dendritic Cell Sarcoma, Interdigitating 28Recurrence 27Myelodysplastic-Myeloproliferative Diseases 26Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 25Leukemia, Myelogenous, Chronic, BCR-ABL Positive 24

Interventions

Fluconazole 5posaconazole 4Voriconazole 4Caspofungin 4Standard of Care 2Itraconazole 2Amphotericin B 2liposomal amphotericin B 1Therapeutics 1ProMune 1Lymphatic Irradiation 1Levofloxacin 1Drug Therapy 1Cyclosporine 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mycoses × Antilymphocyte Serum × Clear all
NCT00896493 2023-05-11

Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma

Stanford University

Phase 2 Completed
38 enrolled 21 charts
DermatologicLymphoid

Lymphoma, Non-Hodgkin, Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡